Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519318 | 0.98 | MEN1 (0.44) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29519177 | 0.98 | MEN1 (0.44) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL7530528 | 0.98 | MEN1 (0.44) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29519084 | 0.98 | MEN1 (0.44) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL2535258 | 0.98 | MEN1 (0.44) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL12036308 | 0.92 | MEN1 (0.47) | MEN1KMT2ATSHRTHRBTGFBR1 | |
| SCHEMBL13862904 | 0.90 | MEN1 (0.50) | MEN1KMT2ATSHRTHRBTGFBR1 | |
| SCHEMBL18016179 | 0.90 | MEN1 (0.50) | MEN1KMT2ATSHRTHRBTGFBR1 | |
| SCHEMBL9420752 | 0.89 | MEN1 (0.40) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL23049027 | 0.86 | THRB (0.38) | MEN1KMT2ATSHRTHRBTGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150010848-A1 | POLYMER ELECTROLYTE MEMBRANE HAVING GRAFT CHAINS, AND METHOD FOR PRODUCING THE SAME | NITTO DENKO CORPORATION (JP) | 2015-01-08 | — | — | US | claimed |
| EP-0615525-B1 | HYDROPHILIC POLY-(N-SUBSTITUTED)ACRYLAMIDE GELS AND THEIR USE IN ELECTROKINETIC AND CHROMATOGRAPHIC METHODOLOGIES | RIGHETTI PIER GIORGIO (IT) | 1998-05-13 | — | — | EP | claimed |
| US-5470916-A | Formulations for polyacrylamide matrices in electrokinetic and chromatographic methodologies | RIGHETTI PIER G (IT) | 1995-11-28 | — | — | US | claimed |
| US-12637809-B2 | Oil-resistant agent composition | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| CN-122094989-A | Polymer, water repellent, fiber product and method for producing fiber product | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4726101-A1 | WATER REPELLENT COMPOSITION AND METHOD FOR PRODUCING SAME | Daikin Industries, Ltd. (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4345138-B1 | OIL-RESISTANT AGENT COMPOSITION | DAIKIN IND LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-3782599-B1 | DENTAL POLYMERIZABLE COMPOSITION BASED ON CONDENSED SILANES | VOCO GMBH (DE) | 2025-09-17 | — | — | EP | disclosed |
| EP-4575089-A1 | METHOD FOR MANUFACTURING PULP PRODUCT | DAIKIN INDUSTRIES, LTD. (JP) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025095118-A1 | POLYMER, WATER REPELLENT AGENT, FIBER PRODUCT, AND METHOD FOR PRODUCING FIBER PRODUCT | ダイキン工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2025095111-A1 | POLYMER, WATER REPELLENT AGENT, FIBER PRODUCT, AND METHOD FOR PRODUCING FIBER PRODUCT | ダイキン工業株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2005080484-A1 | RADIATION HARDENED COMPOSITE LAYER PLATE OR FILM | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| US-6916854-B2 | Heat and/or light curable films or coatings comprising polyurethanes or polyureaurethane copolymers having storage stability, used as automobile paints | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20050025903-A1 | Radiation-hardened coatings with improved adhesive strength | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-03 | — | — | US | disclosed |
| US-20040097642-A1 | Unsaturated compounds containing carbamate terminal groups or urea terminal groups | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| EP-0615525-B1 | HYDROPHILIC POLY-(N-SUBSTITUTED)ACRYLAMIDE GELS AND THEIR USE IN ELECTROKINETIC AND CHROMATOGRAPHIC METHODOLOGIES | RIGHETTI PIER GIORGIO (IT) | 1998-05-13 | — | — | EP | disclosed |
| US-5470916-A | Formulations for polyacrylamide matrices in electrokinetic and chromatographic methodologies | RIGHETTI PIER G (IT) | 1995-11-28 | — | — | US | disclosed |
| EP-0615525-A1 | HYDROPHILIC POLY-(N-SUBSTITUTED)ACRYLAMIDE GELS AND THEIR USE IN ELECTROKINETIC AND CHROMATOGRAPHIC METHODOLOGIES | RIGHETTI, Pier Giorgio (IT) | 1994-09-21 | — | — | EP | disclosed |
| WO-1993011174-A1 | NEW FORMULATIONS FOR POLYACRYLAMIDE MATRICES IN ELECTROKINETIC AND CHROMATOGRAPHIC METHODOLOGIES | RIGHETTI PIER GIORGIO (IT) | 1993-06-10 | — | — | WO | disclosed |
| US-4705753-A | Biologically active acrylonitrile-based copolymeric membrane | GREGOR HARRY P (US) | 1987-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637809-B2 | Oil-resistant agent composition | SLC11A2, HAO2, ALOX12 | MEN1 2968/4885KMT2A 1323/4885TSHR 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.